期刊文献+

鱼精蛋白对寡核苷酸复合物的缩合作用及其对转染效果的影响

Membrane Permeable Peptide-Protamine-Triplex forming Oligodeoxinucleotide Nanoparticles Transfect the Human Umbilical Vein Endothelial cell
下载PDF
导出
摘要 目的观察鱼精蛋白对寡核甘酸复合物的缩合效果。方法用不同浓度鱼精蛋白对寡核甘酸进行缩合,凝胶电泳和扫描电镜观测其缩合结果。将设计的双功能肽与鱼精蛋白和寡核甘酸缩合物进行不同浓度配比后转染脐静脉内皮细胞,激光共聚焦显微镜下观察寡核甘酸入胞效果。结果在鱼精蛋白与寡核甘酸质量比达到1.6∶1以上时能够明显促使寡核甘酸缩合,扫描电镜下观察发现优于脂质体LipofetamineTM2000对该寡核甘酸的缩合。当功能肽与鱼精蛋白和寡核甘酸缩合物以质量比1∶5-1∶10配比复合时能够促使寡核甘酸进入脐静脉内皮细胞且转染率较高。结论优化的双功能肽-鱼精蛋白-寡核苷酸复合法,能够有效地缩合寡核苷酸,并促进寡核甘酸向脐静脉内皮细胞胞内转移。 Objective Optimize the nanoparticles construct with MPP-Protamine-oligodeoxinucleotide,to improve transfection efficiency that Triplex forming oligodeoxinucleotide into human umbilical vein endothelial cell.Methods Synthesize oligodeoxinucleotide labeled by FITC on the 5’ ends.Condensation the oligodeoxinucleotide with different matching Protamine that was evaluated by Gel retardation assay and transmission electron microscop.Construct with MPP-Protamine-oligodeoxinucleotide and observe their transfection efficiencies in HUVEC by laser scanning confocal microscopy.Results oligodeoxinucleotide can be Condensated into nanometer nanoparticles when the matching of Protamine get to 1.6.MPP match with Protamine-oligodeoxinucleotide 1∶10(weight)is higest transfection efficiencies.Conclusion MPP-Protamine-oligodeoxinucleotide is promising to provide a new safe carrier for the intracellular treatmen.
出处 《成都医学院学报》 CAS 2010年第3期196-199,共4页 Journal of Chengdu Medical College
基金 国家自然科学基金项目(NO.39970269) 第三军医大学校管基金项目(2006) 重庆市自然科学基金面上项目(CSTC 2006BB5063)
关键词 双功能肽-鱼精蛋白-寡核苷酸复合法 缩合 转染 脐静脉内皮细胞 Membrane permeable peptide(MPP)-Protamine-Triplex forming oligodeoxinucleotide Transfect Human umbilical vein endothelial cell(HUVEC) Transfection efficiency
  • 相关文献

参考文献9

  • 1Pouton CW,Seymour LW.Key issues in non-viral gene delivery[J].Adv Drug Deliv Rev,2001,46(2):187.
  • 2Jarver P,Lange I U.The use of cell-penetrating peptides as a tool for gene regulation[J].Drug Discov Today,2004,9(9):395-402.
  • 3刘勇,杨在亮,李黔宁.基因转移技术现状及发展[J].西部医学,2008,20(6):1288-1290. 被引量:2
  • 4Tsai JT,Furstoss KJ,Michnick T,et al.Quantitative physical characterization of lipid-polycation-DNA lipopolyplexes[J].Biotechnol Appl Biochem,2002,36(1):13.
  • 5Li S,Rizzo MA,Bhattacharya S,et al.Characterization of cationic lipid-protamine-DNA(LPD)complexes for intravenous gene delivery[J].Gene Therapy,1998,5(8):930.
  • 6Arangoa MA,Düzgünes N,Ilarduya CT.Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes[J].Gene Therapy,2003,10(1):5.
  • 7Schwarze SR,Ho A,Vecero-Akbani A,et al.In vivo protein transduction:delivery of a biologically active protein into the mouse[J].Science,1999,285(5433):1569-1572.
  • 8Matsui H,Tomizawa K,Matsushita M.Protein transduction by poly-arginine[J].Nippon Yakurigaku Zasshi,2003,121(6):435-439.
  • 9Kalderon D,Richardson W D,Markham A F,et al.Sequence requirements for nuclear location of simian virus 40 large-Tantigen[J].Nature,1984,311:33-38.

二级参考文献4

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部